Related references
Note: Only part of the references are listed.MSH2 and adjuvant cisplatin-based chemotherapy in non-small cell lung cancer
P. Fouret et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
OECI Workshop on late side-effects of cancer treatments
R. Arriagada et al.
EUROPEAN JOURNAL OF CANCER (2009)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
Jean-Pierre Pignon et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer
Martin Frueh et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Lung Adjuvant Cisplatin Evaluation: A pooled analysis by the LACE collaborative group
Jean-Pierre Pignon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non-Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups
Gary M. Strauss et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Chemotherapy (CT) in addition to surgery or surgery plus radiotherapy (RT) in non-small cell lung cancer (NSCLC): Two meta-analyses using individual patient data (IPD) from randomised controlled trials (RCTs)
Sarah Burdett et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Noncancer causes of death in survivors of testicular cancer
Sophie D. Fossa et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
Ken A. Olaussen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial
Jean-Yves Douillard et al.
LANCET ONCOLOGY (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Adjuvant chemotherapy for early-stage non-small cell lung cancer
AL Visbal et al.
CHEST (2005)
Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer
BE Johnson et al.
CLINICAL CANCER RESEARCH (2005)
Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer
T Winton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC)
E Felip et al.
ANNALS OF ONCOLOGY (2005)
Long-term sequelae after cancer therapy -: Survivorship after treatment for testicular cancer
SD Fosså
ACTA ONCOLOGICA (2004)
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer
T Le Chevalier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial
D Waller et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2004)
Prophylactic cranial irradiation in high-risk non-small cell lung cancer patients
R Arriagada et al.
LUNG CANCER (2003)
Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer
GV Scagliotti et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Long-term complications of chemotherapy for germ cell tumours
UB Chaudhary et al.
DRUGS (2003)
A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIa non-small-cell lung cancer.
SM Keller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma:: three meta-analyses of updated individual data
JP Pignon et al.
LANCET (2000)
Share Paper
